Mixed lineage kinase 2 and hippocalcin are localized in Lewy bodies of Parkinson's disease

Journal of the Neurological Sciences

Volumn 281, Issue 1-2, 2009, Pages 51-54

  Nagao, Masahiro ^a   Hayashi, Hideaki ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Apoptosis; Calcium sensor protein; ER stress; Glial cytoplasmic inclusion; JNK; Multiple system atrophy; Serine treonine kinase; Synucleopathy

Indexed keywords

HIPPOCALCIN; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; BRAIN; FEMALE; HIPPOCALCIN; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; MALE; MAP KINASE KINASE KINASES; NEURONS; PARKINSON DISEASE;

EID: 67349279111     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.02.375     Document Type: Article

References (19)

1. Chen L., and Feany M.B. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat. Neurosci 8 (2005) 657-663
2. Crocker S.J., Hayley S.P., Smith P.D., Mount M.P., Lamba W.R., Callaghan S.M., et al. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase. J Neurochem 96 (2006) 489-499
3. Gallo K.A., and Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat Rev Mol Cell Biol 3 (2002) 663-672
4. Ganguly A., Qo T.F., Rzhetskaya M., Pratt R., Yarygina O., Momoi T., et al. CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. J Neurochem 88 (2004) 469-480
5. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. α-synuclein in Lewy bodies. Nature 388 (1997) 839-840
6. Kobayashi M., Takamatsu K., Saitoh S., Miura M., and Noguchi T. Molecular cloning of hippocalcin, a novel calcium-binding protein of the recoverin family exclusively expressed in hippocampus. Biochem Biophys Res Commun 189 (1992) 511-5174
7. Kobayashi M., Takamatsu K., Saitoh S., and Noguchi T. Myristoylation of hippocalcin is linked to its calcium-dependent membrane association properties. J Biol Chem 268 (1993) 18898-189045
8. Kobayashi M., Masaki T., Hori K., Masuo Y., Miyamoto M., Tsubokawa H., et al. Hippocalcin-deficient mice display a defect in cAMP response element-binding protein activation associated with impaired spatial and associative memory. Neuroscience 133 (2005) 471-484
9. Lotharius J., Falsig J., van Beek J., Payne S., Dringen R., Brundin P., et al. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25 (2005) 6329-6342
10. Masuo Y., Ogura A., Kobayashi M., Masaki T., Furuta Y., Ono T., et al. Hippocalcin protects hippocampal neurons against exitotoxin damage by enhancing calcium extrusion. Neuroscience 145 (2007) 495-504
11. Mathiasen J.R., McKenna B.A., Saporito M.S., Ghadge G.D., Roos R.P., Holskin B.P., et al. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells. Brain Res 1003 (2004) 86-97
12. Mercer E.A., Korhonen L., Skoglosa Y., Olsson P.A., Kukkonen J.P., and Lindholm D. NAIP interacts with hippocalcin and protects neurons against calcium-induced cell death through caspase-3-dependent and -independent pathways. EMBO J 19 (2000) 3597-3607
13. Nagata K., Puls A., Futter C., Aspenstrom P., Schaefer E., Nakata T., et al. The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J 17 (1998) 149-1588
14. 2+/myristoyl switch protein hippocalcin in living cells. J Cell Biol 163 (2003) 715-7219
15. Onyango I.G., Tuttle J.B., and Bennett Jr. J.P. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids. Mol Cell Neurosci 28 (2005) 452-461
16. Parkinson Study Group. The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD. Neurology 62 (2004) 330-332
17. Silva P.M., Kuan C.Y., Rakic C.P., and Burke R.E. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease. Mov Disord 20 (2005) 653-664
18. Xu Z., Maroney A.C., Dobrzanski P., Kukekov N.V., and Greene L.A. The MLK family mediates c-jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol 21 (2001) 4713-4724
19. Zhang H., and Gallo K.A. Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain. J Biol Chem 276 (2001) 45598-45603